Vanguard Group Inc Exact Sciences Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 17,907,459 shares of EXAS stock, worth $742 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,907,459

Previous 17,637,674 1.53%

Holding current value

$742 Million

Previous $764 Million 24.63%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$40.31 - $58.08 $10.9 Million - $15.7 Million	269,785 Added 1.53%	17,907,459 $952 Million
Q1 2025 May 09, 2025	BUY	$43.04 - $58.51 $26.6 Million - $36.1 Million	617,384 Added 3.63%	17,637,674 $764 Million
Q4 2024 Feb 11, 2025	SELL	$49.33 - $71.97 $36.7 Million - $53.5 Million	-743,624 Reduced 4.19%	17,020,290 $956 Million
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $17.5 Million - $29.1 Million	-411,357 Reduced 2.26%	17,763,914 $1.21 Billion
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $18 Million - $32.3 Million	435,179 Added 2.45%	18,175,271 $768 Million
Q1 2024 May 10, 2024	BUY	$56.27 - $73.77 $10.1 Million - $13.3 Million	180,341 Added 1.03%	17,740,092 $1.23 Billion
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $6.8 Million - $8.71 Million	115,058 Added 0.66%	17,559,751 $1.3 Billion
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $7.89 Million - $11.8 Million	-119,581 Reduced 0.68%	17,444,693 $1.19 Billion
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $10.8 Million - $16.3 Million	171,986 Added 0.99%	17,564,274 $1.65 Billion
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $6.6 Million - $9.9 Million	139,823 Added 0.81%	17,392,288 $1.18 Billion
Q4 2022 Feb 10, 2023	BUY	$30.35 - $53.15 $17.5 Million - $30.6 Million	575,854 Added 3.45%	17,252,465 $854 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $22.3 Million - $34.5 Million	698,740 Added 4.37%	16,676,611 $542 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $12 Million - $25.6 Million	335,877 Added 2.15%	15,977,871 $629 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $12.1 Million - $17.4 Million	210,260 Added 1.36%	15,641,994 $1.09 Billion
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $4.69 Million - $6.51 Million	64,700 Added 0.42%	15,431,734 $1.2 Billion
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $3.93 Million - $5.4 Million	-43,521 Reduced 0.28%	15,367,034 $1.47 Billion
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $1.44 Billion - $2.15 Billion	15,410,555 New	15,410,555 $1.92 Billion

Others Institutions Holding EXAS

# of Institutions

649

Shares Held

157M

Call Options Held

1.45M

Put Options Held

2.29M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.33B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Exact Sciences Corp Transaction History